These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

934 related articles for article (PubMed ID: 10568115)

  • 41. Complement consumption during cardiopulmonary bypass: comparison of Duraflo II heparin-coated and uncoated circuits in fully heparinized patients.
    Hamulu A; Dişcigil B; Ozbaran M; Calkavur T; Kara E; Kokuludağ A; Büket S; Bilkay O
    Perfusion; 1996 Jul; 11(4):333-7. PubMed ID: 8884862
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Beneficial effects of Duraflo II heparin-coated circuits on postperfusion lung dysfunction.
    Ranucci M; Cirri S; Conti D; Ditta A; Boncilli A; Frigiola A; Menicanti L
    Ann Thorac Surg; 1996 Jan; 61(1):76-81. PubMed ID: 8561642
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of pexelizumab, an anti-C5 complement antibody, on total mortality and adverse cardiovascular outcomes in cardiac surgical patients undergoing cardiopulmonary bypass.
    Shernan SK; Fitch JC; Nussmeier NA; Chen JC; Rollins SA; Mojcik CF; Malloy KJ; Todaro TG; Filloon T; Boyce SW; Gangahar DM; Goldberg M; Saidman LJ; Mangano DT;
    Ann Thorac Surg; 2004 Mar; 77(3):942-9; discussion 949-50. PubMed ID: 14992903
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Biomaterial-dependent blood activation during simulated extracorporeal circulation: a study of heparin-coated and uncoated circuits.
    Borowiec JW; Venge P; Henze A; Nilsson B; Stiernström H
    Thorac Cardiovasc Surg; 1997 Dec; 45(6):295-301. PubMed ID: 9477462
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Use of cardiopulmonary bypass decreases leukocyte count and activation of the complement system].
    Bochenek A; Religa Z; Kokot F; Knapik P; Wnuk R; Komarski K; Wojnar J; Pietrzycki A; Skiba J
    Kardiol Pol; 1992; 36(2):67-72. PubMed ID: 1583828
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Complement and granulocyte activation in two different types of heparinized extracorporeal circuits.
    Ovrum E; Mollnes TE; Fosse E; Holen EA; Tangen G; Abdelnoor M; Ringdal MA; Oystese R; Venge P
    J Thorac Cardiovasc Surg; 1995 Dec; 110(6):1623-32. PubMed ID: 8523872
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of blood components exposed to coated arterial filters in extracorporeal circuits.
    Hussaini BE; Treanor PR; Healey NA; Tilahun D; Srey R; Lu XG; Khuri SF; Thatte HS
    Perfusion; 2009 Sep; 24(5):317-23. PubMed ID: 19965951
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Aortic and mitral valve surgery on the beating heart is lowering cardiopulmonary bypass and aortic cross clamp time.
    Gersak B; Sutlic Z
    Heart Surg Forum; 2002; 5(2):182-6. PubMed ID: 12125670
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of heparin-coated circuits with full heparin dose strategy.
    Sinci V; Kalaycioglu S; Gunaydin S; Imren Y; Gokgoz L; Soncul H; Ersoz A
    Ann Thorac Cardiovasc Surg; 1999 Jun; 5(3):156-63. PubMed ID: 10413761
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Heparin-coated circuits reduce activation of granulocytes during cardiopulmonary bypass. A clinical study.
    Borowiec J; Thelin S; Bagge L; Nilsson L; Venge P; Hansson HE
    J Thorac Cardiovasc Surg; 1992 Sep; 104(3):642-7. PubMed ID: 1325013
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Specific complement inhibition with heparin-coated extracorporeal circuits.
    te Velthuis H; Jansen PG; Hack CE; Eijsman L; Wildevuur CR
    Ann Thorac Surg; 1996 Apr; 61(4):1153-7. PubMed ID: 8607674
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The impact of different biocompatible coated cardiopulmonary bypass circuits on inflammatory response and oxidative stress.
    Sohn N; Marcoux J; Mycyk T; Krahn J; Meng Q
    Perfusion; 2009 Jul; 24(4):231-7. PubMed ID: 19858237
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reduction and elimination of systemic heparinization during cardiopulmonary bypass.
    von Segesser LK; Weiss BM; Garcia E; von Felten A; Turina MI
    J Thorac Cardiovasc Surg; 1992 Apr; 103(4):790-8; discussion 798-9. PubMed ID: 1548923
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Complement activation during cardiopulmonary bypass in infants and children. Relation to postoperative multiple system organ failure.
    Seghaye MC; Duchateau J; Grabitz RG; Faymonville ML; Messmer BJ; Buro-Rathsmann K; von Bernuth G
    J Thorac Cardiovasc Surg; 1993 Dec; 106(6):978-87. PubMed ID: 8246580
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evidence for complement activation by protamine-heparin interaction after cardiopulmonary bypass.
    Cavarocchi NC; Schaff HV; Orszulak TA; Homburger HA; Schnell WA; Pluth JR
    Surgery; 1985 Sep; 98(3):525-31. PubMed ID: 3875906
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The impact of allogenic red cell transfusion and coated bypass circuit on the inflammatory response during cardiopulmonary bypass: a randomized study.
    Senay S; Toraman F; Gunaydin S; Kilercik M; Karabulut H; Alhan C
    Interact Cardiovasc Thorac Surg; 2009 Jan; 8(1):93-9. PubMed ID: 18801802
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Using a miniaturized circuit and an asanguineous prime to reduce neutrophil-mediated organ dysfunction following infant cardiopulmonary bypass.
    Karamlou T; Schultz JM; Silliman C; Sandquist C; You J; Shen I; Ungerleider RM
    Ann Thorac Surg; 2005 Jul; 80(1):6-13; discussion 13-4. PubMed ID: 15975331
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Extracorporeal circulation: in vivo and in vitro analysis of complement activation by heparin-bonded surfaces.
    Kirschfink M; Kovacs B; Mottaghy K
    Circ Shock; 1993 Jul; 40(3):221-6. PubMed ID: 8348684
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increased cerebral blood flow velocities assessed by transcranial Doppler examination is associated with complement activation after cardiopulmonary bypass.
    Baufreton C; Pinaud F; Corbeau JJ; Chevailler A; Jolivot D; Ter Minassian A; Henrion D; de Brux JL
    Perfusion; 2011 Mar; 26(2):91-8. PubMed ID: 21173036
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Does heparin coating improve biocompatibility? A study on complement, blood cells and postoperative morbidity during cardiac surgery.
    Belboul A; al-Khaja N
    Perfusion; 1997 Nov; 12(6):385-91. PubMed ID: 9413851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 47.